In section Market Quotes

Sellas Shares Drop 22% After $150 Million Offering Pricing

Sellas Life Sciences Group shares fell 22% to $13.98 in premarket trading Thursday after the biopharmaceutical company priced a public offering intended to raise $150 million. The decline followed a sharp run-up: through Wednesday’s close, the stock had more than quadrupled year to date.

Sellas said late Wednesday it would sell more than 11.5 million shares of common stock at $13 each. Underwriters also received a 30-day option to buy up to about 1.73 million additional shares at the offering price, less discounts and commissions.

J.P. Morgan and TD Cowen are the lead book-running managers. The offering is expected to close Friday.

Share:on TelegramXFacebook

Subscribe to our newsletter

Once a week — the best stories from our editors, no ads or push notifications. Delivered Sunday morning.

Comments (0)

Leave a comment

No comments yet. Be the first!